menu
    • menu

    Company profile for Fulcrum Therapeutics

    NEW Drugs in Dev: 3
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We launched Fulcrum Therapeutics with a bold vision: To change the course of genetically defined diseases by treating them at their root cause. Our approach to drug discovery generates significant insights into disease biology and allows us to think creatively about the best way to modulate and balance gene expression. The result: A patient-focused product engine designed to systematically identify and validate cellular drug ...
    We launched Fulcrum Therapeutics with a bold vision: To change the course of genetically defined diseases by treating them at their root cause. Our approach to drug discovery generates significant insights into disease biology and allows us to think creatively about the best way to modulate and balance gene expression. The result: A patient-focused product engine designed to systematically identify and validate cellular drug targets that can modulate gene expression to treat the known root cause of genetically defined diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Fulcrum TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    26 Landsdowne Street Cambridge, MA 02139
    Telephone
    Telephone
    617-651-8851
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.fulcrumtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/fulcrum-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/fulcrumtx/

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fulcrum Therapeutics Issues Inducement Grants Under Nasdaq Rule
    Fulcrum Therapeutics Issues Inducement Grants Under Nasdaq Rule

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3291350/0/en/fulcrum-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    Fulcrum Pharma Appoints Josh Lehrer To Board
    Fulcrum Pharma Appoints Josh Lehrer To Board

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3281444/0/en/fulcrum-therapeutics-appoints-josh-lehrer-to-its-board-of-directors.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    Fulcrum Therapeutics Reports Q1 2026 Financial Results
    Fulcrum Therapeutics Reports Q1 2026 Financial Results

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3281455/0/en/fulcrum-therapeutics-announces-recent-business-highlights-and-financial-results-for-first-quarter-2026.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    Fulcrum Therapeutics' Q1 2026 Call & Webcast: Apr 27, 4:30 PM ET
    Fulcrum Therapeutics' Q1 2026 Call & Webcast: Apr 27, 4:30 PM ET

    20 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/20/3276939/0/en/fulcrum-therapeutics-to-host-first-quarter-2026-financial-results-conference-call-and-webcast-on-monday-april-27-2026-at-8-00-a-m-et.html

    GLOBENEWSWIRE
    20 Apr 2026
    Share Share
    SCDAA, MedicAlert, Fulcrum Partner to Speed Sickle Cell ED Access
    SCDAA, MedicAlert, Fulcrum Partner to Speed Sickle Cell ED Access

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3258908/0/en/MedicAlert-Foundation-Sickle-Cell-Disease-Association-of-America-Inc-SCDAA-and-Fulcrum-Therapeutics-Partner-to-Accelerate-Emergency-Department-Access-to-Critical-Care-Information-f.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Fulcrum Reports Inducement Grants Under Nasdaq LR 5635(c)(4)
    Fulcrum Reports Inducement Grants Under Nasdaq LR 5635(c)(4)

    06 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/06/3251332/0/en/Fulcrum-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    06 Mar 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search